Anne-Laure Vallier

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Lucy Rivett, Sushmita Sridhar, Dominic Sparkes et al. · eLife · 2020 · 569 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 283 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · Journal of Clinical Oncology · 2018 · 70 citations

Medicine, Oncology, Pharmacotherapy +17

Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study

Dami A. Collier, Sonny Michael Assennato, Ben Warne et al. · Cell Reports Medicine · 2020 · 63 citations · Full text

Medicine, Infectious Diseases, Diagnostic Microbiology +16

Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19

Nick K Jones, Lucy Rivett, Dominic Sparkes et al. · eLife · 2020 · 55 citations · Full text

Medicine, Infectious Disease Control, Infectious Diseases +17